Pharmacokinetic evaluation of fingolimod for the treatment of multiple sclerosis

Author： Tanasescu Radu Constantinescu Cris S

ISSN： 1742-5255

Source： Expert Opinion on Drug Metabolism and Toxicology, Vol.10, Iss.4, 2014-04, pp. : 621-630

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Fingolimod for the treatment of relapsing multiple sclerosis

By Singer Barry A

Expert Review of Neurotherapeutics, Vol. 13, Iss. 6, 2013-06 ,pp. : 589-602

Informa Healthcare

Access to resources Recommend Favorite

Pharmacokinetic evaluation of nabiximols for the treatment of multiple sclerosis pain

By Tanasescu Radu Constantinescu Cris S

Expert Opinion on Drug Metabolism and Toxicology, Vol. 9, Iss. 9, 2013-09 ,pp. : 1219-1228

Informa Healthcare

Access to resources Recommend Favorite

Pharmacokinetic evaluation of teriflunomide for the treatment of multiple sclerosis

By Wiese Michael D

Expert Opinion on Drug Metabolism and Toxicology, Vol. 9, Iss. 8, 2013-08 ,pp. : 1025-1035

Informa Healthcare

Access to resources Recommend Favorite

Determination of Seminal Concentration of Fingolimod and Fingolimod‐Phosphate in Multiple Sclerosis Patients Receiving Chronic Treatment With Fingolimod

Clinical Pharmacology In Drug Development, Vol. 7, Iss. 2, 2018-02 ,pp. : 217-221

John Wiley & Sons Inc

Access to resources Recommend Favorite

Fingolimod for relapsing multiple sclerosis: an update

By Horga Alejandro Castilló Joaquín Montalban Xavier

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 7, 2010-05 ,pp. : 1183-1196

Informa Healthcare

Access to resources Recommend Favorite